UnknownNCT04221997
Sertraline response and blood markers in children with anxiety
About this title
Read the official source — NCT04221997Medication studyAges 8–17United States
Understand this study
Who could participate?
Listed age limits: 8 years to 17 years.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 1, 2019
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 150
- Sponsor
- University of Cincinnati
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 8 Years to 17 Years
- Official registry ID
- NCT04221997
- Official title
Show the full official title
Extracellular Vesicles as Predictors of Antidepressant Outcomes in Pediatric Anxiety (EV-SOPRANO)
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Cincinnati, a university.
Does this study involve medication?
Yes. The study involves medication, including sertraline.
Who can participate?
Listed age limits: 8 years to 17 years.
